A behind-the-scenes look at how Replior rebuilt its EDC from the ground up—designed to adapt to real-world trial needs with greater flexibility, control, and speed.

After 20 years in clinical trials, Katri Langel reflects on what’s changed, what hasn’t, and why she joined Replior to help fix what’s broken.

What’s next for clinical trials? See our top takeaways from SCOPE 2025, including how sensor-driven data and patient engagement are changing the game.

Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.

Learn how EDC systems play a vital role in GDPR compliance for clinical trials, supporting data security, audit trails, and participant consent management.

Learn how to solve retention, compliance, and data quality challenges in clinical trials, drawing insights from our eBook.

Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.

Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.

Reflecting on 2023, this CEO message highlights Replior’s achievements, lessons learned, and steps taken to prepare for future growth and innovation in clinical trials.